Review: taking Allegra and Claritin together


Summary

Drug interactions are reported among people who take Allegra and Claritin together. This review analyzes the effectiveness and drug interactions between Allegra and Claritin. It is created by eHealthMe based on reports of 833 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Allegra and Claritin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Allegra

Allegra has active ingredients of fexofenadine hydrochloride. It is often used in hypersensitivity. (latest outcomes from Allegra 25,605 users)

Claritin

Claritin has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Claritin 22,301 users)

On Jul, 22, 2016

833 people who take Allegra, Claritin are studied.


Number of reports submitted per year:

Allegra and Claritin drug interactions.

Drug effectiveness over time:

Allegra:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 25.0% - (1 of 4 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Claritin:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 66.0% - (2 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 6 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Allegra:
  • female: 57.0% - (4 of 7 people)
  • male: 0.0% - (0 of 6 people)
Claritin:
  • female: 33.0% - (2 of 6 people)
  • male: 16.0% - (1 of 6 people)

Drug effectiveness by age:

Allegra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 4 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 66.0% - (2 of 3 people)
  • 60+: 0.0% - (0 of 2 people)
Claritin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 4 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • loss of consciousness
  • epilepsy
  • atrial fibrillation
  • malaise
  • convulsion
  • vomiting
  • dehydration
  • nausea
  • pyrexia
  • decreased appetite
1 - 6 months:
  • anaemia
  • anxiety
  • complications of transplanted kidney
  • confusional state
  • dyspnoea
  • muscle pain
  • pain - joints
  • procedural pain
  • pulmonary congestion
  • therapeutic response decreased
6 - 12 months:
  • headache
  • hypoaesthesia
  • influenza like illness
  • nausea
  • paraesthesia
  • vomiting
1 - 2 years:
  • anxiety
  • depression
  • osteomyelitis
  • periodontitis
  • raynaud's phenomenon
  • renal disorder
  • scleroderma
  • gastrooesophageal reflux disease
  • back pain
  • fatigue
2 - 5 years:
  • cholecystitis
  • nausea
  • adverse event
  • arthropathy
  • depression
  • dizziness
  • drug ineffective
  • femur fracture
  • gastrooesophageal reflux disease
  • headache
5 - 10 years:
  • dyspnoea
  • anxiety
  • arthralgia
  • pain
  • amnesia
  • depression
  • insomnia
  • aggression
  • biliary dyskinesia
  • biopsy breast abnormal
10+ years:
  • abnormal behaviour
  • aggression
  • amnesia
  • anxiety
  • delusion
  • depression
  • fear
  • hallucination
  • insomnia
  • irritability
not specified:
  • pain
  • depression
  • anxiety
  • back pain
  • nausea
  • fatigue
  • dyspnoea
  • oedema peripheral
  • arthralgia
  • gastrooesophageal reflux disease

Most common drug interactions by gender *:

female:
  • depression
  • pain
  • anxiety
  • back pain
  • arthralgia
  • fall
  • oedema peripheral
  • nausea
  • gastrooesophageal reflux disease
  • chest pain
male:
  • depression
  • anxiety
  • dyspnoea
  • dizziness
  • myocardial infarction
  • pleural effusion
  • pyrexia
  • fatigue
  • gastrooesophageal reflux disease
  • vomiting

Most common drug interactions by age *:

0-1:
  • drug exposure during pregnancy
  • immature respiratory system
  • premature baby
2-9:
  • anxiety
  • muscle pain
  • pain - joints
  • tic
  • arrhythmia
  • sudden death
  • unresponsive to stimuli
  • vomiting
  • abdominal pain
  • drug level increased
10-19:
  • drug ineffective
  • acute respiratory failure
  • coma
  • urinary incontinence
  • abdominal pain upper
  • cardiac arrest
  • chest pain
  • dyspnoea
  • pulse absent
  • syncope
20-29:
  • pain
  • anxiety
  • tachycardia
  • musculoskeletal pain
  • pulmonary embolism
  • weight increased
  • abdominal distension
  • asthenia
  • biliary dyskinesia
  • blood pressure decreased
30-39:
  • depression
  • abdominal pain
  • blood triglycerides increased
  • pain in extremity
  • blood cholesterol increased
  • bronchitis
  • fall
  • fatigue
  • joint swelling
  • sinusitis
40-49:
  • chest pain
  • drug ineffective
  • nausea
  • dyspnoea
  • weight increased
  • arthralgia
  • depression
  • vomiting
  • pyrexia
  • sinusitis
50-59:
  • anxiety
  • depression
  • pain
  • fatigue
  • oedema peripheral
  • nausea
  • back pain
  • fall
  • injury
  • headache
60+:
  • dyspnoea
  • oedema peripheral
  • anxiety
  • depression
  • gastrooesophageal reflux disease
  • pain
  • anaemia
  • arthralgia
  • pneumonia
  • back pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Allegra and Claritin?

Can you answer these questions?

More questions for: Allegra, Claritin

You may be interested in these reviews

More reviews for: Allegra, Claritin

On eHealthMe, Allegra (fexofenadine hydrochloride) is often used to treat hypersensitivity. Claritin (loratadine) is often used to treat hypersensitivity. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.